X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse TTK HEALTHCARE with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TTK HEALTHCARE   ADCOCK INGRAM
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
ADCOCK INGRAM
Jun-14
TTK HEALTHCARE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs663368-   
Low Rs399266-   
Sales per share (Unadj.) Rs535.6109.6-  
Earnings per share (Unadj.) Rs15.9-27.6-  
Cash flow per share (Unadj.) Rs20.0-22.9-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.686.0-  
Shares outstanding (eoy) m7.77168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.02.9 34.3%   
Avg P/E ratio x33.3-11.5 -290.1%  
P/CF ratio (eoy) x26.5-13.9 -191.4%  
Price / Book Value ratio x3.93.7 104.7%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,12753,502 7.7%   
No. of employees `0001.74.3 39.8%   
Total wages/salary Rs m6073,358 18.1%   
Avg. sales/employee Rs Th2,436.74,307.3 56.6%   
Avg. wages/employee Rs Th355.2782.2 45.4%   
Avg. net profit/employee Rs Th72.5-1,085.3 -6.7%   
INCOME DATA
Net Sales Rs m4,16218,491 22.5%  
Other income Rs m61129 47.3%   
Total revenues Rs m4,22318,621 22.7%   
Gross profit Rs m197-3,204 -6.2%  
Depreciation Rs m32798 4.0%   
Interest Rs m30501 6.0%   
Profit before tax Rs m197-4,374 -4.5%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73273 26.6%   
Profit after tax Rs m124-4,659 -2.7%  
Gross profit margin %4.7-17.3 -27.3%  
Effective tax rate %37.0-6.2 -592.3%   
Net profit margin %3.0-25.2 -11.8%  
BALANCE SHEET DATA
Current assets Rs m1,62913,543 12.0%   
Current liabilities Rs m1,0587,620 13.9%   
Net working cap to sales %13.732.0 42.8%  
Current ratio x1.51.8 86.6%  
Inventory Days Days30111 26.8%  
Debtors Days Days34124 27.1%  
Net fixed assets Rs m5567,894 7.0%   
Share capital Rs m7886 90.5%   
"Free" reserves Rs m8780-   
Net worth Rs m1,06914,514 7.4%   
Long term debt Rs m1595,100 3.1%   
Total assets Rs m2,39927,417 8.8%  
Interest coverage x7.6-7.7 -98.0%   
Debt to equity ratio x0.10.4 42.2%  
Sales to assets ratio x1.70.7 257.2%   
Return on assets %6.4-15.2 -42.3%  
Return on equity %11.6-32.1 -36.1%  
Return on capital %18.5-19.8 -93.2%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Net fx Rs m-300-   
CASH FLOW
From Operations Rs m1271,578 8.0%  
From Investments Rs m-146-485 30.1%  
From Financial Activity Rs m224,629 0.5%  
Net Cashflow Rs m35,723 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.08 Rs / ZAR

Compare TTK HEALTHCARE With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare TTK HEALTHCARE With: ABBOTT INDIA  FDC LTD.  CADILA HEALTHCARE  IPCA LABS  PANACEA BIOTECH  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views On News

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 22, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS